Prescribing of psychotropic medications to children and adolescents: quo vadis? - Wikidata - wikimedia - TriplyDB

Prescribing of psychotropic medications to children and adolescents: quo vadis?

Prescribing of psychotropic medications to children and adolescents: quo vadis?

http://www.wikidata.org/entity/Q36930857

about

Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.Psychopharmacological Prescriptions in Children and Adolescents in Germany BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents.

P2860

Q34292768-FA736C54-6FF9-47B5-B28F-D1927BE45437 Q37067376-5867ECE3-52F4-44F6-9568-5E4795E3C59D Q50217112-31BA621A-0B56-467F-A8B6-2A7616486BE5

P2860

Prescribing of psychotropic medications to children and adolescents: quo vadis?

http://www.wikidata.org/entity/Q36930857

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Prescribing of psychotropic medications to children and adolescents: quo vadis?

@en

type

label

Prescribing of psychotropic medications to children and adolescents: quo vadis?

@en

prefLabel

Prescribing of psychotropic medications to children and adolescents: quo vadis?

@en

P1433

Q36930857-D956711D-9565-4541-BFEB-78A69651E17B

P1476

Q36930857-936FE64B-05C6-44C8-A48A-91EEF0DE263C

P2093

Q36930857-043A7669-1BBE-474F-A14A-23C62E15F722

Q36930857-44DCEF57-716F-492C-A3C1-184FB79F7481

P2860

Q36930857-175A6E14-B13E-4244-B3F8-D4A23E7AB0DA

Q36930857-4A94802C-575E-417C-9F1D-E5A6BB7B40B1

Q36930857-7D1B90BC-5549-4655-A720-078BD78C5791

Q36930857-A474BBED-B10A-4ABD-9A26-D37A389AAB92

Q36930857-C92F8CD5-6A6D-473F-A062-7C3FC4E53385

Q36930857-CA58D1EE-ACE8-421F-ACFA-E72DF9EBC62C

P304

Q36930857-934E8DB6-DC3B-4ACA-B671-F4F1B400AD55

P31

Q36930857-1FB0CDE0-DA65-47FE-B67A-D39CC048A3E7

P356

Q36930857-A3A82E27-80BC-494E-AF56-57519153DBAC

P407

Q36930857-6AA7F228-33C2-4C4D-BDF1-8CA7927C1524

P433

Q36930857-42C9E216-0624-4876-A8DC-2B47F385317D

P478

Q36930857-BF4B7E4E-8EC4-431B-9825-9836C3D586F0

P50

Q36930857-E51B7899-D8A4-4C58-91A6-1B83B603E3DB

P577

Q36930857-0E75C9BA-C02A-4EF2-B22A-09E0588D0D9C

P5875

Q36930857-191B6554-FC82-48DC-A5DF-CACFAFC7996A

P698

Q36930857-F23D900C-A99C-4CA5-B1A8-AEA9ECFD8E29

P932

Q36930857-9D61F33B-05F7-46C7-AD28-6C00F5A00345

P356

P1433

World Psychiatry

P1476

Prescribing of psychotropic medications to children and adolescents: quo vadis?

@en

P2093

Christoph U Correll

http://www.w3.org/2001/XMLSchema#string

Mark Olfson

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults?

Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement

Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.

National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.

P304

127-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/WPS.20031

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237057406

http://www.w3.org/2001/XMLSchema#string

P698

23737416

http://www.w3.org/2001/XMLSchema#string

P932

3683259

http://www.w3.org/2001/XMLSchema#string